These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23430446)

  • 1. Is the BCR-ABL1 transcript type in chronic myeloid leukaemia relevant?
    Langabeer SE
    Med Oncol; 2013 Jun; 30(2):508. PubMed ID: 23430446
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia.
    Bennour A; Ouahchi I; Achour B; Zaier M; Youssef YB; Khelif A; Saad A; Sennana H
    Med Oncol; 2013 Mar; 30(1):348. PubMed ID: 23269583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.
    Loncarevic IF; Römer J; Starke H; Heller A; Bleck C; Ziegler M; Fiedler W; Liehr T; Clement JH; Claussen U
    Genes Chromosomes Cancer; 2002 Jun; 34(2):193-200. PubMed ID: 11979553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An atypical (b3/a3) junction of the bcr/abl gene lacking abl exon a2 in a patient with chronic myeloid leukemia.
    Amabile M; Martinelli G; Terragna C; Montefusco V; Tabilio A; Tura S
    Haematologica; 1999 Jun; 84(6):573-5. PubMed ID: 10366813
    [No Abstract]   [Full Text] [Related]  

  • 5. Decreased microRNA-30a levels are associated with enhanced ABL1 and BCR-ABL1 expression in chronic myeloid leukemia.
    Liu Y; Song Y; Ma W; Zheng W; Yin H
    Leuk Res; 2013 Mar; 37(3):349-56. PubMed ID: 23287430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology of chronic myelogenous leukemia.
    Tanzer J
    Nouv Rev Fr Hematol (1978); 1991; 33(2):197-200. PubMed ID: 1766852
    [No Abstract]   [Full Text] [Related]  

  • 7. Genotype-phenotype correlation of unusual BCR-ABL1 transcripts in Philadelphia chromosome-positive leukaemia.
    Gong Z; Zhou T; Liu H; Tang G; Yin CC; Wang W; Medeiros LJ; Hu S
    Br J Haematol; 2020 Jun; 189(5):e207-e211. PubMed ID: 32237084
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of a novel variant BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia: Implications for molecular monitoring.
    Crampe M; Haslam K; Kelly J; Conneally E; Langabeer SE
    Hematol Oncol Stem Cell Ther; 2017 Jun; 10(2):85-88. PubMed ID: 27013275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
    Prejzner W
    Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the BCR-ABL1 fusion transcripts on different responses to Imatinib and disease recurrence in Iranian patients with Chronic Myeloid Leukemia.
    Rostami G; Hamid M; Jalaeikhoo H
    Gene; 2017 Sep; 627():202-206. PubMed ID: 28627443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine structure of translocation breakpoints within the major breakpoint region in BCR-ABL1-positive leukemias.
    Burmeister T; Gröger D; Kühn A; Hoelzer D; Thiel E; Reinhardt R
    DNA Repair (Amst); 2011 Nov; 10(11):1131-7. PubMed ID: 21944569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR-ABL transcript having a DNA breakpoint between ABL exons a2 and a3.
    Liu LG; Tanaka H; Ito K; Kyo T; Ito T; Kimura A
    Am J Hematol; 2003 Dec; 74(4):268-72. PubMed ID: 14635208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCR-ABL transcript with an e19a2 (c3a2) junction in classical chronic myeloid leukemia.
    Wilson G; Frost L; Goodeve A; Vandenberghe E; Peake I; Reilly J
    Blood; 1997 Apr; 89(8):3064. PubMed ID: 9108430
    [No Abstract]   [Full Text] [Related]  

  • 14. Localisation and distance between ABL and BCR genes in interphase nuclei of bone marrow cells of control donors and patients with chronic myeloid leukaemia.
    Lukásová E; Kozubek S; Kozubek M; Kjeronská J; Rýznar L; Horáková J; Krahulcová E; Horneck G
    Hum Genet; 1997 Oct; 100(5-6):525-35. PubMed ID: 9341866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.
    Metzke-Heidemann S; Harder L; Gesk S; Schoch R; Jenisch S; Grote W; Siebert R; Schlegelberger B
    Genes Chromosomes Cancer; 2001 May; 31(1):10-4. PubMed ID: 11284030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
    Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
    Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patients.
    Ross DM; O'Hely M; Bartley PA; Dang P; Score J; Goyne JM; Sobrinho-Simoes M; Cross NC; Melo JV; Speed TP; Hughes TP; Morley AA
    Leukemia; 2013 Oct; 27(10):2105-7. PubMed ID: 23588714
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare e14a3 (b3a3) BCR-ABL fusion in chronic myeloid leukemia in India: the threats and challenges in monitoring minimal residual disease (MRD).
    Vaniawala S; Acharya A; Parekh H; Mukhopadhyaya PN
    Anal Cell Pathol (Amst); 2013; 36(3-4):85-92. PubMed ID: 24072036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCR/ABL fusion located on chromosome 9 in chronic myeloid leukemia with a masked Ph chromosome.
    Mohamed AN; Koppitch F; Varterasian M; Karanes C; Yao KL; Sarkar FH
    Genes Chromosomes Cancer; 1995 Jun; 13(2):133-7. PubMed ID: 7542908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.